The role of genomics and genetics in pulmonary arterial hypertension

Emilia M Swietlik, Stefan Gräf, Nicolas W Morrell


[No abstract. Showing first paragraph of article]

Although pulmonary hypertension (PH) had been recognised for centuries, it was not until the invention of cardiac catheterisation in the 1950s that enabled an accurate gene encoding bone morphogenetic protein receptor type 2, in patients with familial and clinical diagnosis. The discovery of heterozygous germline mutations in BMPR2, the idiopathic forms of pulmonary arterial hypertension (PAH) was another breakthrough in understanding the disease and initiated a new era in care of patients with this condition.

Full Text:




  • There are currently no refbacks.

Copyright (c) 2020 Emilia M Swietlik, Stefan Gräf, Nicolas W Morrell

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.